Mesoblast says remestemcel-L will continue to be in demand
MELBOURNE: Mesoblast chairman Joseph Swedish says the company’s rock star drug remestemcel-L will ... read more
Hospitals may be sold as Healthe Care regroups
MELBOURNE: Australia’s third-largest private hospital operator Healthe Care is believed to be in ... read more
